Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

Name: Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
Published: 2015
License: Public Domain

M.D. Anderson Cancer Center · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

leukemia

leukemia, hemophagocytic lymphohistiocytosis, hlh, alemtuzumab, campath-1h, campath, etoposide, vepesid, dexamethasone, decadron, methotrexate, phone call

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 807618
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.